Chemours Stock Price, News & Analysis (NYSE:CC)

$16.19
-0.21 (-1.28 %)
(As of 09/23/2019 01:03 AM ET)
Today's Range
$15.78
Now: $16.19
$16.47
50-Day Range
$11.77
MA: $14.26
$18.56
52-Week Range
$11.71
Now: $16.19
$42.12
Volume2.74 million shs
Average Volume3.37 million shs
Market Capitalization$2.65 billion
P/E Ratio2.86
Dividend Yield6.10%
Beta2.57
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. Read More…

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
CUSIPN/A
Phone302-773-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$6.64 billion
Cash Flow$7.6730 per share
Book Value$5.96 per share

Profitability

Net Income$995 million

Miscellaneous

Employees7,000
Market Cap$2.65 billion
Next Earnings Date11/7/2019 (Estimated)
OptionableOptionable

Receive CC News and Ratings via Email

Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.


Chemours (NYSE:CC) Frequently Asked Questions

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Wednesday, July 31st. Investors of record on Friday, August 16th will be paid a dividend of $0.25 per share on Monday, September 16th. This represents a $1.00 annualized dividend and a yield of 6.18%. The ex-dividend date is Thursday, August 15th. View Chemours' Dividend History.

How will Chemours' stock buyback program work?

Chemours announced that its Board of Directors has authorized a stock buyback program on Monday, December 4th 2017, which allows the company to buyback $500,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Stock buyback programs are often a sign that the company's leadership believes its stock is undervalued.

How were Chemours' earnings last quarter?

Chemours Co (NYSE:CC) released its quarterly earnings data on Thursday, August, 1st. The specialty chemicals company reported $0.72 EPS for the quarter, missing analysts' consensus estimates of $0.90 by $0.18. The specialty chemicals company had revenue of $1.41 billion for the quarter, compared to analyst estimates of $1.53 billion. Chemours had a return on equity of 71.90% and a net margin of 10.33%. Chemours's revenue was down 22.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.71 earnings per share. View Chemours' Earnings History.

When is Chemours' next earnings date?

Chemours is scheduled to release their next quarterly earnings announcement on Thursday, November 7th 2019. View Earnings Estimates for Chemours.

What guidance has Chemours issued on next quarter's earnings?

Chemours issued an update on its FY19 earnings guidance on Thursday, August, 1st. The company provided earnings per share (EPS) guidance of $2.37-3.08 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.88.

What price target have analysts set for CC?

11 equities research analysts have issued 1 year price targets for Chemours' stock. Their predictions range from $16.00 to $52.00. On average, they anticipate Chemours' share price to reach $31.30 in the next twelve months. This suggests a possible upside of 93.3% from the stock's current price. View Analyst Price Targets for Chemours.

What is the consensus analysts' recommendation for Chemours?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 6 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Chemours.

Has Chemours been receiving favorable news coverage?

Press coverage about CC stock has trended somewhat negative recently, InfoTrie reports. The research firm scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Chemours earned a news impact score of -1.3 on InfoTrie's scale. They also assigned headlines about the specialty chemicals company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Chemours.

Are investors shorting Chemours?

Chemours saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 11,297,200 shares, an increase of 34.8% from the July 31st total of 8,381,000 shares. Based on an average trading volume of 3,220,000 shares, the days-to-cover ratio is presently 3.5 days. Approximately 7.0% of the company's stock are short sold. View Chemours' Current Options Chain.

Who are some of Chemours' key competitors?

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include Micron Technology (MU), E I Du Pont De Nemours And Co (DD), NVIDIA (NVDA), DowDuPont (DWDP), Alibaba Group (BABA), Cisco Systems (CSCO), Johnson & Johnson (JNJ), AT&T (T), Intel (INTC) and Applied Materials (AMAT).

Who are Chemours' key executives?

Chemours' management team includes the folowing people:
  • Mr. Mark P. Vergnano, Pres, CEO & Director (Age 61)
  • Mr. Mark E. Newman, Sr. VP & CFO (Age 56)
  • Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 55)
  • Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 62)
  • Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 55)

Who are Chemours' major shareholders?

Chemours' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.85%), BlackRock Inc. (9.85%), Vanguard Group Inc. (9.48%), Third Point LLC (2.68%), LSV Asset Management (2.36%) and Bank of New York Mellon Corp (1.70%). Company insiders that own Chemours stock include Amy Trojanowski, Bradley J Bell, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano, Mary B Cranston, Paul Kirsch, Richard H Brown and Susan M Kelliher. View Institutional Ownership Trends for Chemours.

Which major investors are selling Chemours stock?

CC stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., BlackRock Inc., BlackRock Inc., Royal Bank of Canada, Schroder Investment Management Group, Schroder Investment Management Group, Parametric Portfolio Associates LLC and Bank of New York Mellon Corp. Company insiders that have sold Chemours company stock in the last year include Amy Trojanowski, Mark Newman and Paul Kirsch. View Insider Buying and Selling for Chemours.

Which major investors are buying Chemours stock?

CC stock was acquired by a variety of institutional investors in the last quarter, including Third Point LLC, Invesco Ltd., Connor Clark & Lunn Investment Management Ltd., M&T Bank Corp, Morgan Stanley, WINTON GROUP Ltd, Nuveen Asset Management LLC and W.E. Donoghue & Co. LLC. Company insiders that have bought Chemours stock in the last two years include Bradley J Bell, David C Shelton, E Bryan Snell, Mark Newman, Mark P Vergnano, Mary B Cranston, Richard H Brown and Susan M Kelliher. View Insider Buying and Selling for Chemours.

How do I buy shares of Chemours?

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $16.19.

How big of a company is Chemours?

Chemours has a market capitalization of $2.65 billion and generates $6.64 billion in revenue each year. The specialty chemicals company earns $995 million in net income (profit) each year or $5.67 on an earnings per share basis. Chemours employs 7,000 workers across the globe.View Additional Information About Chemours.

What is Chemours' official website?

The official website for Chemours is http://www.chemours.com/.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19899. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]


MarketBeat Community Rating for Chemours (NYSE CC)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  439 (Vote Outperform)
Underperform Votes:  484 (Vote Underperform)
Total Votes:  923
MarketBeat's community ratings are surveys of what our community members think about Chemours and other stocks. Vote "Outperform" if you believe CC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/23/2019 by MarketBeat.com Staff

Featured Article: Elliott Wave Theory

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel